25 min listen
Anabolic Therapy for Osteoporosis
ratings:
Length:
23 minutes
Released:
Jul 27, 2021
Format:
Podcast episode
Description
Anabolic drugs activate osteoblasts and are an alternative to bisphosphonates for treating osteoporosis. Kristine Ensrud, MD, MPH, professor of medicine and epidemiology at the University of Minnesota and Minneapolis VA Healthcare System, joins JAMA Associate Editor Carolyn Crandall, MD, MS, to discuss the role of teriparatide, abaloparatide, and romosozumab in the management of osteoporosis. Related Content: Anabolic Therapy for Osteoporosis
Released:
Jul 27, 2021
Format:
Podcast episode
Titles in the series (100)
Graves Disease: Edward H. Livingston, MD discusses Graves disease with David Cooper, MD, author of by JAMA Clinical Reviews